OMC
LFCR icon

Old Mission Capital’s Lifecore Biomedical LFCR Stock Holding History

Old Mission Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,505
Closed -$208K – 1462
2023
Q2 		$208K Buy
+21,505
New +$131K ﹤0.01% 980

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Old Mission Capital's LFCR Position: Q3 2023 in Review

Old Mission Capital sold out of Lifecore Biomedical (LFCR) in Q3 2023, closing a stake of 21,505 shares — an estimated $208K sold.

Old Mission Capital first reported a position in LFCR in Q2 2023 and held it in 1 quarter. The position peaked at $208K in Q2 2023. 69 funds tracked by Wall St. Rank hold LFCR as of Q3 2023.

  • Old Mission Capital reported no remaining Lifecore Biomedical position as of Q3 2023 after selling out during the quarter.
  • Old Mission Capital sold 21,505 Lifecore Biomedical shares in Q3 2023, an estimated $208K.
  • Old Mission Capital first reported a position in Lifecore Biomedical in Q2 2023 and held it in 1 quarter.
  • Old Mission Capital's Lifecore Biomedical position peaked at $208K in Q2 2023.
  • 69 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2023.

Based on Old Mission Capital's 13F filing for Q3 2023, filed 15 Nov 2023.